These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 11695839

  • 1. Effect of testosterone replacement therapy on serum PSA in patients with Klinefelter syndrome.
    Shibasaki T, Sasagawa I, Suzuki Y, Yazawa H, Ichiyanagi O, Matsuki S, Miura M, Nakada T.
    Arch Androl; 2001; 47(3):173-6. PubMed ID: 11695839
    [Abstract] [Full Text] [Related]

  • 2. Prostate volume and growth during testosterone replacement therapy is related to visceral obesity in Klinefelter syndrome.
    Selice R, Caretta N, Di Mambro A, Torino M, Palego P, Ferlin A, Foresta C.
    Eur J Endocrinol; 2013 Dec; 169(6):743-9. PubMed ID: 24001894
    [Abstract] [Full Text] [Related]

  • 3. Effects of gonadotropin and testosterone treatments on prostate volume and serum prostate specific antigen levels in male hypogonadism.
    Ozata M, Bulur M, Beyhan Z, Sengül A, Saglam M, Turan M, Corakci A, Ali Gundogan M.
    Endocr J; 1997 Oct; 44(5):719-24. PubMed ID: 9466329
    [Abstract] [Full Text] [Related]

  • 4. Prostate cancer following testosterone replacement in Klinefelter syndrome.
    Bydder SA, Joseph DJ, Weinstein S, Stuckey BG.
    ANZ J Surg; 2007 Oct; 77(1-2):93-4. PubMed ID: 17295832
    [Abstract] [Full Text] [Related]

  • 5. Testosterone replacement therapy and prostate/seminal vesicle volume in Klinefelter's syndrome.
    Sasagawa I, Nakada T, Kazama T, Terada T, Katayama T.
    Arch Androl; 1989 Oct; 22(3):245-9. PubMed ID: 2502953
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of testosterone replacement therapy in adolescents with Klinefelter syndrome.
    Mehta A, Clearman T, Paduch DA.
    J Urol; 2014 May; 191(5 Suppl):1527-31. PubMed ID: 24679877
    [Abstract] [Full Text] [Related]

  • 7. Prostate cancer in Klinefelter syndrome during hormonal replacement therapy.
    Hwang JJ, Dharmawardana PG, Uchio EM, Wynberg J, Phillips JL.
    Urology; 2003 Nov; 62(5):941. PubMed ID: 14624928
    [Abstract] [Full Text] [Related]

  • 8. [Testosterone level not significantly correlates to endothelial progenitor cells in Klinefelter's syndrome patients].
    Ru BZ, Gao XC, Yue WW, Hu P.
    Zhonghua Nan Ke Xue; 2012 Jan; 18(1):67-9. PubMed ID: 22295853
    [Abstract] [Full Text] [Related]

  • 9. Effect of testosterone replacement therapy on bone mineral density in patients with Klinefelter syndrome.
    Jo DG, Lee HS, Joo YM, Seo JT.
    Yonsei Med J; 2013 Nov; 54(6):1331-5. PubMed ID: 24142635
    [Abstract] [Full Text] [Related]

  • 10. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
    Grober ED, Lamb DJ, Khera M, Murthy L, Lipshultz LI.
    Int J Impot Res; 2008 Nov; 20(6):561-5. PubMed ID: 18843272
    [Abstract] [Full Text] [Related]

  • 11. Prostate-specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment.
    Raynaud JP, Gardette J, Rollet J, Legros JJ.
    BJU Int; 2013 May; 111(6):880-90. PubMed ID: 23294726
    [Abstract] [Full Text] [Related]

  • 12. Effect of growth hormone (GH) and/or testosterone replacement on the prostate in GH-deficient adult patients.
    Colao A, Di Somma C, Spiezia S, Filippella M, Pivonello R, Lombardi G.
    J Clin Endocrinol Metab; 2003 Jan; 88(1):88-94. PubMed ID: 12519835
    [Abstract] [Full Text] [Related]

  • 13. Effect of sex hormone treatment on circulating adiponectin and subforms in Turner and Klinefelter syndrome.
    Høst C, Bojesen A, Frystyk J, Flyvbjerg A, Christiansen JS, Gravholt CH.
    Eur J Clin Invest; 2010 Mar; 40(3):211-9. PubMed ID: 20100236
    [Abstract] [Full Text] [Related]

  • 14. Effects of depot testosterone therapy on serum levels of luteinizing hormone and follicle-stimulating hormone in patients with Klinefelter's syndrome and hypogonadotropic eunuchoidism.
    Fukutani K, Isurugi K, Takayasu H, Wakabayashi K, Tamaoki B.
    J Clin Endocrinol Metab; 1974 Nov; 39(5):856-64. PubMed ID: 4418679
    [No Abstract] [Full Text] [Related]

  • 15. Successful testicular sperm retrieval in adolescents with Klinefelter syndrome treated with at least 1 year of topical testosterone and aromatase inhibitor.
    Mehta A, Bolyakov A, Roosma J, Schlegel PN, Paduch DA.
    Fertil Steril; 2013 Oct; 100(4):970-4. PubMed ID: 23830150
    [Abstract] [Full Text] [Related]

  • 16. Testosterone and the child (0-12 years) with Klinefelter syndrome (47XXY): a review.
    Fennoy I.
    Acta Paediatr; 2011 Jun; 100(6):846-50. PubMed ID: 21284716
    [Abstract] [Full Text] [Related]

  • 17. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory.
    Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM.
    J Urol; 2011 Sep; 186(3):1005-11. PubMed ID: 21788049
    [Abstract] [Full Text] [Related]

  • 18. Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy.
    Rhoden EL, Morgentaler A.
    Int J Impot Res; 2006 Sep; 18(2):201-5. PubMed ID: 16177827
    [Abstract] [Full Text] [Related]

  • 19. Dutasteride in men receiving testosterone therapy: a randomised, double-blind study.
    Kacker R, Harisaran V, Given L, Miner M, Rittmaster R, Morgentaler A.
    Andrologia; 2015 Mar; 47(2):148-52. PubMed ID: 24499051
    [Abstract] [Full Text] [Related]

  • 20. The effect of testosterone replacement therapy on prostate-specific antigen (PSA) levels in men being treated for hypogonadism: a systematic review and meta-analysis.
    Kang DY, Li HJ.
    Medicine (Baltimore); 2015 Jan; 94(3):e410. PubMed ID: 25621688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.